Artemisinin Confers Neuroprotection against 6-OHDA-Induced Neuronal Injury In Vitro and In Vivo through Activation of the ERK1/2 Pathway
Molecules · 2023
DOI: 10.3390/molecules28145527 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Qin Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center of Reproduction, Development & Aging and Institute of Translation Medicine, Faculty of Health Sciences, University of Macau, Room 3057, Buildi…. Hauptthemen laut MEDLINE: Parkinson Disease, Neuroprotective Agents, Neurodegenerative Diseases, Neuroblastoma. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Development Fund, Macau SAR, Guangdong Provincial Funding Committee for Basic and Applied Fundamental Research.
Abstract (Originalsprache)
Parkinson’s disease (PD) is an age-related, progressive neurodegenerative disease characterized by the gradual and massive loss of dopaminergic neurons in the substantia nigra pars compacta (SNc). We have recently reported that artemisinin, an FDA-approved first-line antimalarial drug, possesses a neuroprotective effect. However, the effects and underlying mechanisms of artemisinin on Parkinson’s disease remain to be elucidated. In this study, we investigated the neuroprotective effects of artemisinin on 6-OHDA and MPP+ in neuronal cells and animal models, as well as the underlying mechanisms. Our results showed that artemisinin significantly attenuated the loss of cell viability, LDH release, elevated levels of reactive oxygen species (ROS), the collapse of the mitochondria trans-membrane potential and cell apoptosis in PC12 cells. Western blot results showed that artemisinin stimulated the phosphorylation of ERK1/2, its upstream signaling proteins c-Raf and MEK and its downstream target CREB in PC12 cells in a time- and concentration-dependent manner. In addition, the protective effect of artemisinin was significantly reduced when the ERK pathway was blocked using the ERK pathway inhibitor PD98059 or when the expression of ERK was knocked down using sgRNA. These results indicate the essential role of ERK in the protective effect of artemisinin. Similar results were obtained in SH-SY5Y cells and primary cultured neurons treated with 6-OHDA, as well as in cellular models of MPP+ injury. More interestingly, artemisinin attenuated PD-like behavior deficit in mice injected with 6-OHDA evaluated by behavioral tests including swimming test, pole-test, open field exploration and rotarod tests. Moreover, artemisinin also stimulated the phosphorylation of ERK1/2, inhibited apoptosis, and rescued dopaminergic neurons in SNc of these animals. Application of ERK pathway inhibitor PD98059 blocked the protective effect of artemisinin in mice during testing. Taking these results together, it was indicated that artemisinin preserves neuroprotective effects against 6-OHDA and MPP+ induced injury both in vitro and in vivo by the stimulation of the ERK1/2 signaling pathway. Our findings support the potential therapeutic effect of artemisinin in the prevention and treatment of Parkinson’s disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center of Reproduction, Development & Aging and Institute of Translation Medicine, Faculty of Health Sciences, University of Macau, Room 3057, Building E12, Taipa, Macau SAR 999078, China.
- School of pharmacy, Hangzhou Medical College, Hangzhou 310059, China.
- Guangdong Provincial Engineering Research Center of Molecular Imaging, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai 519000, China.
- Department of Neurology, Zhujiang Hospital of Southern Medical University, Guangzhou 510280, China.
ORCID-Profile: Qing Wang, Wenhua Zheng
Förderung
- National Natural Science Foundation of China
- Science and Technology Development Fund, Macau SAR
- Guangdong Provincial Funding Committee for Basic and Applied Fundamental Research
- Natural Science Foundation of Zhejiang Province
- Medical and health Science and Technology Project of Zhejiang Province
- University of Macau
Zitieren
APA
Li, Q., Li, S., Fang, J., Yang, C., Zhao, X., Wang, Q., Zhou, W., & Zheng, W. (2023). Artemisinin Confers Neuroprotection against 6-OHDA-Induced Neuronal Injury In Vitro and In Vivo through Activation of the ERK1/2 Pathway. Molecules. https://doi.org/10.3390/molecules28145527
Vancouver
Li Q, Li S, Fang J, Yang C, Zhao X, Wang Q, et al. Artemisinin Confers Neuroprotection against 6-OHDA-Induced Neuronal Injury In Vitro and In Vivo through Activation of the ERK1/2 Pathway. Molecules. 2023. doi:10.3390/molecules28145527
BibTeX
@article{Li2023,
author = {Li, Qin and Li, Shuai and Fang, Jiankang and Yang, Chao and Zhao, Xia and Wang, Qing and Zhou, Wenshu and Zheng, Wenhua},
title = {Artemisinin Confers Neuroprotection against 6-OHDA-Induced Neuronal Injury In Vitro and In Vivo through Activation of the ERK1/2 Pathway},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28145527}
}
EUVIMED